Intravesical gemcitabine and docetaxel vs. re‐induction Bacillus Calmette Guerin as first‐line salvage therapy for non‐muscle invasive bladder cancer

Abstract Objectives To compare the outcomes between re‐induction Bacillus Calmette‐Guérin (BCG) and sequential intravesical gemcitabine‐docetaxel (Gem/Doce) therapy in patients with high‐grade (HG) non‐muscle invasive bladder cancer (NMIBC) following failure of initial induction BCG. Materials and m...

全面介紹

書目詳細資料
發表在:BJUI Compass
Main Authors: Kylie Yen‐Yi Lim, Tran Ngoc An Huynh, Gavin Wei, Jincy Kuriakose, Obaidullah Fazli, David Pook, Sarah Ransley, Janice Downie, Scott Donnellan, Weranja Ranasinghe
格式: Article
語言:英语
出版: Wiley 2025-04-01
主題:
在線閱讀:https://doi.org/10.1002/bco2.70012

相似書籍